IsoRay (ISR) Ships First International GliaSite Orders to Germany
IsoRay Inc. (AMEX: ISR) announced another step forward in international adoption of its ground-breaking GliaSite radiation therapy system, the world's only liquid radiation balloon catheter device used in the treatment of brain cancers. IsoRay shipped its first orders to Germany as mounting inquiries continue to grow Company confidence in the international market. According to IsoRay CEO Dwight Babcock, "The medical community is clearly becoming aware of the innovative alternative that GliaSite presents as an important advance over previous brain cancer treatments. We are seeing a growth in inquiries from Germany, Italy, Austria, Switzerland, and the United Kingdom."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gynecologic Cancers Successfully Treated Using IsoRay's Cesium-131 Will Be Presented by Dr. Jonathan Feddock Saturday Night While at the Society of Gynecologic Oncology Convention (SGO)
- Rockwell Medical (RMTI) Triferic Data Selected for Four Poster Presentations at KNF
- IsoRay's (ISR) Cesium-131 Used to Successfully Treat Gynecologic Cancers
Create E-mail Alert Related CategoriesCorporate News, FDA
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!